SUMMARY Concentrations of prolactin, follicle stimulating hormone, luteinising hormone and growth hormone were measured simultaneously in the serum and cerebrospinal fluid of 57 patients affected by neurologic disease without any pituitary or diencephalic involvement. Prolactin secretion was stimulated in another group of 12 patients using sulpiride or metoclopramide, and the hormone concentration was measured simultaneously in serum and in CSF during the test. Basal studies showed that the concentrations of prolactin, FSH, LH and GH in serum and in CSF were directly correlated (p varying from less than 0 001 to less than 0-05). A negative correlation was found between the molecular weight of hormones reported in this and in other studies and the natural logarithm of the CSF/serum hormone concentration ratios. During prolactin stimulation the correlation between serum and CSF concentration was maintained, nevertheless a higher increase of prolactin in blood than in CSF was observed. This last finding suggests that other mechanisms in addition to filtration from blood into CSF can be responsible for the presence of adenohypophyseal hormones in CSF.
Materials and methods
Basal studies Concentration of prolactin (PRL), follicle stimulating hormone (FSH) , luteinising hormone (LH) and growth hormone (GH) have been measured simultaneously in serum and in CSF in 57 patients with different neurologic diseases without any pituitary or diencephalic involvement. In some CSF samples it was not possible to measure all the hormones; the relative number of samples assayed for each hormone was 43, 28, 28, 21 for PRL, FSH, LH and GH respectively. CSF was taken during diagnostic lumbar puncture (40 patients) and during iodoventriculography or insertion of ventricle-atrial shunts from the lateral ventricle (17 patients). The patients studied were affected by intervertebral disks herniation (15), cerebrovascular diseases (6) , cerebral neoplasms (19) and miscellaneous neurologic diseases (17).
Studies during prolactin pituitary stimulation These studies were performed in 12 patients who received sulpiride or metoclopramide prior to lumbar puncture. Sulpiride was administered to seven patients, in daily doses Relationship between circulating levels ofadenohypophyseal hormones in blood and cerebrospinal fluid 711 and in CSF were simultaneously measured in these patients sodium 100 mg plus succinylcholine 25 mg iv and at the end of the stimulation period, when monitoring of fluothane) before iodoventriculography. serum PRL levels showed that steady serum PRL levels Radioimmunoassay of adenohypophyseal hormones was were reached. None of the patients studied had received performed using RIA kits supplied by Sorin Biomedica, medication or anaesthesia except a very young patient in Italy (for LH, FSH, GH) and by Biodata, Italy (for PRL). the basal study group (pt. 22, table 1) who had received In our laboratory, before the menopause, the upper normedication (promethazine hydrochloride 25 mg plus mal limits for FSH, LH and PRL serum concentrations are atr6pine sulphate 0-5 mg iv) and anaesthesia (thiopental 9-5, 23 and 25 ng/ml respectively; after the menopause these values are 53, 21 and 15 ng/ml respectively. In men the upper normal limits for these hormones are 2-8, 2-9 and 15 ng/ml. The upper limit of the normal range is 6 ng/ml for GH. The intraassay and interassay coefficients of variation are 4 5 % and 9%, 6% and 11%, 5% and 13%, 5% and 10% for PRL, FSH, LH and GH respectively. The limits of detectability of the hormone concentrations were 0 5, 0-21, 0-2 and 1 ng/ml for LH, FSH, GH and PRL respectively.
Results Table 1 shows the hormonal serum and CSF values of the studies performed in basal conditions. (Table 3) . The measurable FSH and LH CSF concentrations were significantly correlated with the age of the patients (p < 0*01 and p < 0-05 respectively). During pharmacological stimulation of PRL secretion, a positive correlation was found between the hormone concentration in serum and in CSF (r = 0-734 p < 0.01). When all the studies were taken into account (during basal and stimulated PRL secretion), a direct correlation was also found between PRL concentration in serum and in CSF (fig 1) . The ratio serum/CSF PRL concentration was higher during stimulated PRL secretion than during basal PRL secretion (fig 2) . No '4'8-20 Correlations between serum and CSF concentrations of FSH, LH and ACTH have not been found in most of the studies.'52' In our study it is likely that elderly menopausal patients with relatively high serum levels of FSH and LH have increased the range of concentrations explored, helping to detect the correlation between serum and CSF values. The correlation between serum and CSF PRL concentrations in patients with basal PRL secretion is significant because of the three patients with slight elevation of PRL serum levels (Pt. 5, 15, 23 table 1). Therefore we cannot affirm that this correlation is maintained when serum PRL levels are in normal range. However, the finding that most of the adenohypophyseal hormones studied show CSF concentrations related to those of serum seems to favour the hypothesis of the hormonal filtration at the choroid plexuses from blood into CSF. The hypothesis of hormonal filtration from blood into CSF is also suggested by fig 3 which shows the correlation between the CSF/serum ratio and the molecular weight of the hormones studied together with other pituitary and extrapituitary hormones. The CSF/serum ratios for ACTH, insulin, calcitonin, HCG and HCS are those reported in different studies carried out in basal conditions.' 8 9 14 It can be seen that an inverse correlation is found between the two parameters (CSF/ serum ratio and molecular weight) when all the hormones are taken into account. This finding suggests that the hormonal molecular weight affects the CSF/serum ratio. As the same correlation has been reported22 between the plasma/CSF concentration ratio and the molecular weight of blood proteins it could be inferred that the adenohypophyseal hormones, which have a molecular weight less than that of albumin, enter the CSF by the same route as the various blood proteins. Nevertheless a PRL increase higher in blood than in CSF and quite different PRL serum/CSF ratios (ranging from 5*5 to 14.2) are 714 found for increased serum concentrations (fig 2) . These findings cannot be explained by a slowly increasing PRL passage into CSF as no correlation in our study has been observed between the duration of PRL stimulation and the serum/CSF ratio and it has been reported in animals that peak plasma PRL values occur 30 min after pituitary stimulation followed by the peak CSF PRL levels with a delay of 60 min. 23 The same finding also has been reported for insulin in basal patients.8 A lower CSF/serum PRL ratio in basal studies could hypothetically be due to an essay error for lower PRL levels; but if this methodological limit did not occur these last observations disagree with the hypothesis of only passive diffusion and seem to suggest that also other mechanisms (that is, saturable or retrograde transport, extra-pituitary cerebral production) can be responsible for the presence of the hormone in CSF. A similar suggestion derives from the PRL and GH mean serum/CSF ratios which, in our study (table  1) , and also in others,34 1 8 are lower than that of HCS reported in the literature '4 in spite of the same molecular weight. Also, since most peptide hormones secreted from the brain, like HCS, do not show any correlation between their serum and CSF values9-24 25 it could be that the blood-CSF barrier differs depending on the hormone involved and on its cerebral or extra-cerebral origin.
In conclusion our study shows that serum FSH, LH, GH and PRL hormone concentrations seem to influence the levels in the CSF and supports the hypothesis that a different mechanism affects the presence of PRL in CSF. It is, however, evident that further studies are necessary to define better the actual contribution of filtration and of the other hypothesised mechanisms of the entry of the adenohypophyseal hormones into the CSF.
